Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
May 4th, 2020
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Accepted into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging
April 30th, 2020
Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital
April 21st, 2020
Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
April 15th, 2020
Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
April 14th, 2020
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
April 2nd, 2020
Applied DNA Ships LinearDNA™ to Another Development Customer
March 26th, 2020
Provisional Patent Application Filed for High Sensitivity COVID-19 Diagnostic Assay
March 24th, 2020
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20th, 2020
